Intrinsiqq
Tectonic Therapeutic Inc. logo

Tectonic Therapeutic Inc. Financials

TECX

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 9 available years
Income Statement
DEC 2025
~2.2:1 split
DEC 2024
~2.3:1 split
DEC 2023
DEC 2022
DEC 2021
Cost of Revenue-$80-$54-$41-$102–
General & Administrative$21$17$8$33$36
Research & Development$63$41$37$72$83
Total Operating Expenses$84$58$45$105$119
Operating Income-$84-$58-$45-$105-$119
Non-Operating
Net Interest Expense$11$4$0-$2-$0
Other Non-Operating Income (Expense)-$0-$4$2-$0-$0
EBT (Earnings Before Tax)-$73-$58–––
Income Tax Expense$1$0$0$0–
Net Income
Net Income-$74-$58-$43-$106-$119
EPS (Basic)-$4.05-$6.83-$33.76-$29.04-$33.36
EPS (Diluted)-$4.05-$6.83-$33.76-$29.04-$33.36
Weighted Avg Shares (Basic)18.3M8.5M44.3M43,73942,854
Weighted Avg Shares (Diluted)18.3M8.5M44.6M43,73942,854
Shares Outstanding18.3M8.5M3.7M3.6M3.6M
Dividends Per Share$0.00$0.00–––

Tectonic Therapeutic (TECX) financials: revenue, profit and margins

Tectonic Therapeutic (TECX) generated about n/a in revenue and -$88 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Tectonic Therapeutic profitable?+

Tectonic Therapeutic reported about -$88 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 30 Oct 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 11 Nov 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with TECX

CompareIntrinsic value
RGNXRegenxbio Inc.
$7.16-0.28%36
ENTXEntera Bio Ltd.
$3.31+0.76%20
ATYRAtyr Pharma Inc.
$3.82+3.52%10
ELUTElutia Inc.
$0.89+8.54%20
AUTLAutolus Therapeutics plc
$0.91-7.45%40
IKTInhibikase Therapeutics Inc.
$1.31+0.38%10
HUMAHumacyte, Inc.
$0.45-17.97%0
PALIPalisade Bio Inc.
$0.84-9.69%20

Held by ETFs

TECX is in 10 US ETFs. The largest of them, with TECX's weight in each:

Spot a number that looks wrong? Check it in TECX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing TECX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.